Wegovy and Ozempic are brand names for semaglutide and are approved to promote weight loss, improve blood sugar control, and enhance metabolic health
J., Best, A
doi: 10.1002/edm2.v7.1 11 PerkovicVTuttleKRRossingPMahaffeyKWMannJFEBakrisGet al
During the first quarter, Ozempic sales leaped 42% year-over-year, from DKK 19.640 billion ($2.826 billion) to DKK 27.810 billion ($4.002 billion)
When comparing a semaglutide pill vs injection, consider needle preference, dosing routine, and specific health goals
3 In the REIMAGINE 1 trial, the most commonly reported adverse events (AEs) were gastrointestinal (GI)-related, occurring in 33/62 (53%) participants in the CagriSema 2.4 mg/2.4 mg group, 28/63 (44%) participants in the CagriSema 1 mg/1 mg group, and 13/64 (20%) participants in the placebo group